Content with Tipo de contenido .
Productivity and market growth: Microsoft and Izertis link AI deployment to security and data
Microsoft and Izertis agree in a discussion that AI will boost productivity and the IT market, and will positively transform employment.
Izertis strengthens its Software Engineering to lead in the era of AI
Izertis strengthens its Software Engineering through AI, SDD and QA to improve quality, accelerate development, and lead solutions in key sectors.
Izertis closes 2025 with solid growth and consolidates its financial strength
Izertis closed 2025 with solid growth, higher revenues and profitability, strengthening its liquidity and international expansion following several integrations.
AETHERIA, the platform to end the 'maze' of the medical record
AETHERIA uses AI to convert medical data into the HL7 FHIR standard, stores it in a secure wallet, and allows patients to share it privately.
Izertis and Talentia Software strengthen their strategic alliance to drive the modernisation of financial management in Spain and Portugal
Izertis and Talentia Software are expanding their strategic collaboration with the aim of accelerating the modernisation of financial management in companies in Spain and Portugal.
Izertis once again among the 1,000 fastest growing companies in Europe
Izertis has once again been listed among the 1,000 fastest-growing companies in Europe, according to the FT1000 - Europe's Fastest-Growing Companies 2026 ranking.
Izertis and Xygeni join forces to improve security control in the software development cycle
Izertis has reached a collaboration agreement with Xygeni, a company specialising in application security and software supply chain control.
Izertis completes a €54.1 million share placement with the entry of leading institutional investors
Izertis boosts its growth with a record €54.1 million placement backed by major international institutional investors and demand 2.3 times the offered amount.
UTERIAM: AI and bio-manufacturing to advance health
UTERIAM combines AI, 3D bioprinting and advanced bioinks to create uterine tissue cultures that accurately replicate the human physiological environment.